PREVENTIONGENETICS INC.

In News

Exact Sciences Acquires PreventionGenetics to Accelerate Availability of Hereditary Cancer Testing for More Patients - PR Newswire

PR Newswire - Jan 09, 2022

PreventionGenetics Assumes the Management of Sponsored Genetic Testing Program for Three Rare Genetic Diseases: Acute Hepatic Porphyria, Primary Hyperoxaluria Type 1 & Hereditary ATTR Amyloidosis - Business Wire

Business Wire - Mar 13, 2025

What to know about Exact Sciences. The Madison company was sold to Abbottfor $23 billion. - Yahoo Finance

Yahoo Finance - Nov 20, 2025

Exact Sciences makes $190 million acquisition, enters licensing agreement - In Business Madison

In Business Madison - Jan 11, 2022

EXACT SCIENCES CORP SEC 10-K Report - TradingView

TradingView - Feb 13, 2026

Exact Sciences buys genetics lab for $190M to enter hereditary cancer testing market - The Business Journals

The Business Journals - Jan 10, 2022

Rare Disease Genetic Testing Market Size | CAGR Of 13.1% - Market.us

Market.us - Apr 18, 2023

Rare Disease Genetic Testing Market Size Report 2026-2033 - Grand View Research

Grand View Research - Jun 01, 2020

Key facts: Exact Sciences to merge with Abbott by Q2 2026; 2025 revenue up 18% - TradingView

TradingView - Feb 14, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment